We are researching the business implications for all stakeholders, how to support the clinical workforce, and the likely impact on pregnant patients and their families.Get the latest
The Dobbs v. Jackson ruling has triggered a cascade of consequences for health care leaders and the people they serve and has introduced unprecedented complexity to organizations operating across state lines. We have been working to understand the implications for the health care industry as a whole and for different stakeholders across the industry.
To learn more about how the Dobbs decision will impact health care industry-wide, visit these resources:
Read on to dive deeper into the decision’s key implications by stakeholder and issues to watch.
The human impact from Roe v. Wade’s overturn is bigger than just the people seeking abortion care. It will lead to a shift in downstream community care needs and care utilization patterns that will impact the health care industry and all patients more broadly.
Clinicians’ autonomy over care decisions is being questioned, presenting legal risks and moral distress for an already burned-out workforce.
Telehealth volumes likely will increase as telehealth becomes a key access point for people seeking abortion care, but some state laws restricting abortion access could pose dangers for patient and provider privacy.
Hospital and health system leaders may be quick to think about how Roe v. Wade’s overturn might affect their organizations’ volumes and revenue, but the legal risks that emerging state laws could place on both their workforce and their organizations present a much bigger challenge.
Health care employers must be ready to discuss and address abortion access in the workplace, while also navigating new legal and reputational risks.
With laws on abortion access and reproductive care now varying from state to state, purchasers and health plans will need to balance decisions about which services to cover with feasibility to offer equal benefits for their entire membership—and that ultimately could affect where they operate.
Life sciences, pharmaceutical, and medical device companies will need to address changes in demand and utilization patterns for the products they make, including medication abortion drugs, contraceptives, and other medications and devices used in women’s health care—and potentially beyond.
Create your free account to access 2 resources each month, including the latest research and webinars.
You have 2 free members-only resources remaining this month remaining this month.
Never miss out on the latest innovative health care content tailored to you.